14
Dec
2026

Swiss Parenterals Limited

Exhibitor at CPHI Middle East 2026 stand H2.F19
About Us

Swiss Parenterals is a third-generation pharmaceutical export company with a presence in over 65 countries. With more than 25 years of expertise, we are recognized as a leading manufacturer of generic and specialty pharmaceutical products.Our portfolio includes:General and complex injectablesInhalation solutionsLyophilized productsDry powder injectionCephalosporins, Carbapenems, and Penicillin formulations. 
Our facilities hold approvals from multiple global regulatory agencies including: EUGMP, PIC/S, ANVISA, INVIMA and Others

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    India
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    500 - 999
Company types
Pharmaceutical company
Primary activities
Contract Manufacturer
Contract Research Organisation
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • +919909006246
  • Website
  • 62 Titanium, 6th Floor,, Near Auda Garden, Near Sales India, Prahalad Nagar,100 Feet Rring Road, Satellite, 380 015, Ahmedabad, Gujarat, India
Show contact info Hide contact info
Event information
CPHI Middle East 2026
  • 14 Dec 2026 - 16 Dec 2026
  • Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
  • Visit us at stand H2.F19

Products Featured at CPHI Middle East 2026

  • Aztreonam Injection

    Product Aztreonam Injection

    Aztreonam Injection
  • ceftazidime/avibactam

    Product ceftazidime/avibactam

    (2g/0.5g)/vial: 2.5gEquivalent to 2.635 grams of ceftazidime pentahydrate/sodium carbonate powder and 0.551 grams of avibactam sodium
  • Ferric carboxymaltose injection

    Product Ferric carboxymaltose injection

    Ferric carboxymaltose injection
  • Semaglutide injection

    Product Semaglutide injection

    Semaglutide injection is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. This medicine is also used to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes, obesity, and heart or blood vessel disease. It is also used t...
  • Phenobarbiton tablets b.p

    Product Phenobarbiton tablets b.p

    SWISS PARENTERALS PVT LTD offers wide range of prodcuts which includes phenobarbiton tablets b.p. Packaging: 60 mg. Contact us for more information.

Swiss Parenterals Limited. Resources (1)